Delivery Order SPE2DR25D1103-SPE2DR26FE943
- Not listed
- The Defense Logistics Agency awarded a $16,726.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The order, which is part of a non-set-aside competitive procurement, is scheduled for completion by January 20, 2026, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $16,367.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors on January 9, 2026, with a completion date of January 12, 2026. This non-set-aside award was issued as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where the...
- On January 22, 2026, the Defense Logistics Agency awarded a delivery order valued at $5,149.59 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price, non-set-aside contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.99 billion through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare...
- The Defense Logistics Agency awarded a $17,436.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 22, 2026, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The delivery order has an ultimate completion date of January 23, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order valued at $38,597.17 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion scheduled for December 10, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply vehicle running through December...
- The Defense Logistics Agency awarded a $16,080.68 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with completion scheduled for November 4, 2025. This non-competitive delivery order employs firm fixed price pricing and will be performed at the contractor's Conshohocken, Pennsylvania headquarters. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $32,449.31 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors on January 8, 2026, with an ultimate completion date of January 9, 2026. This competitively awarded, firm fixed-price contract requires performance at the awardee's facility in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's parent company, Cencora, Inc.'s, $999,999,999.00 Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $25,207.11 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of June 26, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency has awarded a delivery order valued at $9,427.34 to AmerisourceBergen Drug Corp for the supply of ENBREL 50 MG/ML SureClick auto-injector medication. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, operates under firm fixed pricing with no set-aside designation. Performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite...
- The Defense Logistics Agency awarded a $48,764.11 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of December 29, 2025. This competitive award employs firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE943Delivery Order
The Defense Logistics Agency awarded a $8,333.51 delivery order to AmerisourceBergen Drug Corp on January 27, 2026, for the supply of ENBREL 50 mg/mL SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with performance completion targeted for January 28, 2026, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999 through December 2026, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and wholly-owned subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), both of which function as critical vendors in the federal medical procurement supply chain. The company has demonstrated substantial capability in fulfilling government contracts through open competition across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This particular delivery order for ENBREL, a biologic immunosuppressant used in treating rheumatoid arthritis and other inflammatory conditions, represents routine execution of the company's existing IDC vehicle to support Defense Health Agency and military treatment facility requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 1/26/26 |